Focus
team
approach
programs
patients
News
careers
Contact
Back
Press Releases
In The News
Publications
Focus
team
approach
programs
patients
News
Press Releases
In The News
Publications
careers
Contact
Press Releases
Featured
Dec 12, 2018
Frank S. Czerwiec, M.D., Ph.D. joins Goldfinch Bio as Chief Medical Officer
Dec 12, 2018
Dec 12, 2018
Oct 29, 2018
Goldfinch Bio Announces GFB-887 as Clinical Development Candidate and Presents Data Demonstrating Selective Inhibition of TRPC5 for the Treatment of Genetically-driven Kidney Disease
Oct 29, 2018
Oct 29, 2018
Oct 5, 2018
GOLDFINCH BIO TO PRESENT DATA ON TRPC5 INHIBITOR FOR PROTEINURIC KIDNEY DISEASE AND ITS KIDNEY GENOME ATLAS FOR IDENTIFICATION OF NOVEL TARGETS
Oct 5, 2018
Oct 5, 2018
Jun 1, 2018
Goldfinch Bio to Present at Jefferies 2018 Global Healthcare Conference
Jun 1, 2018
Jun 1, 2018
May 31, 2018
Goldfinch Bio Presents Data on TRPC5 Inhibition as a Target for Proteinuric Kidney Disease and Announces GFB-887 as Lead Drug Program to treat FSGS
May 31, 2018
May 31, 2018
Mar 19, 2018
Goldfinch Bio to Present at BioCentury’s Future Leaders in Biotech Industry Conference
Mar 19, 2018
Mar 19, 2018
Mar 13, 2018
Goldfinch Bio Bolsters Leadership Team by Appointing Dr. Peter Mundel as Chief Scientific Officer and Electing Dr. Frank Maddux to Board of Directors
Mar 13, 2018
Mar 13, 2018
Mar 6, 2018
Goldfinch Bio to Present at Cowen and Company Healthcare Conference
Mar 6, 2018
Mar 6, 2018
Oct 17, 2017
Goldfinch Bio Announces Collaborations with Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to Augment World’s Largest Genomic Registry of Patients with Kidney Disease
Oct 17, 2017
Oct 17, 2017
Oct 3, 2017
Goldfinch Bio and NEPTUNE Announce Collaboration to Discover New Treatments for Patients with Kidney Disease
Oct 3, 2017
Oct 3, 2017
Sep 26, 2017
Goldfinch Bio Expands Leadership Team with World-Class Preclinical and Clinical Expertise to Augment Company’s Unprecedented Investigation into the Molecular Drivers of Kidney Disease
Sep 26, 2017
Sep 26, 2017
Feb 9, 2017
Goldfinch Bio Appoints Nephrologist Louis Brenner, M.D., M.B.A. to Board of Directors
Feb 9, 2017
Feb 9, 2017
Dec 14, 2016
Third Rock Ventures launches Goldfinch Bio with $55M in Series A funding to bring precision medicine to patients with kidney disease
Dec 14, 2016
Dec 14, 2016
Read About Goldfinch
In The News